| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 20 |
| 1 | BOSENTAN | 13 |
| 2 | SILDENAFIL CITRATE | 11 |
| 3 | FUROSEMIDE | 7 |
| 4 | SILDENAFIL | 7 |
| 5 | ASPIRIN | 6 |
| 6 | ASPIRIN 325 MG | 6 |
| 7 | ASPIRIN 81 MG | 6 |
| 8 | RIVAROXABAN | 6 |
| 9 | SILDENAFIL POWDER, | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COUMARIN | 1 | 0.0061 |
| 1 | ILOPROST | 1 | 0.0011 |
| 2 | NIZATIDINE | 1 | 0.0007 |
| 3 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 4 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 5 | FONDAPARINUX SODIUM | 3 | 0.0004 |
| 6 | ECULIZUMAB | 20 | 0.0004 |
| 7 | PAMIDRONATE DISODIUM | 1 | 0.0003 |
| 8 | BOSENTAN | 13 | 0.0003 |
| 9 | GLUTAMINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | Complement Inhibitor [EPC] | 20 | 0.0004 |
| 2 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 3 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 6 | 0.0000 |
| 7 | Cardiac Glycoside [EPC] | 3 | 0.0000 |
| 8 | Prostacycline Vasodilator [EPC] | 5 | 0.0000 |
| 9 | Iron Chelator [EPC] | 1 | 0.0000 |